Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Synchrony Financial (SYF:NYSE), powered by AI.
Synchrony Financial is currently trading at $75.29. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Synchrony Financial on Alpha Lenz.
Synchrony Financial's P/E ratio is 7.8.
“Synchrony Financial trades at a P/E of 7.8 (undervalued) with strong ROE of 21.3%.”
Ask for details →Synchrony Financial is a consumer financial services company primarily focused on providing private-label credit cards. It serves as a key partner to a variety of retailers, manufacturers, and healthcare providers, enabling them to offer customized credit solutions to their customers. Synchrony Financial's products extend beyond credit cards to include promotional financing, installment lending, and loyalty programs, often aimed at enhancing customer retention and satisfaction for its partners. The company plays a significant role in industries such as retail, health and wellness, automotive, and home, where it provides targeted financial solutions that are integrated into the point of sale. This integration makes Synchrony a crucial player in consumer finance, as it supports both businesses and consumers through flexible payment options. Headquartered in Stamford, Connecticut, Synchrony Financial was established in 2003. It is a major issuer of private-label credit cards in the United States, contributing to the retail sector's growth by empowering consumers to make purchases and manage payments over time. The company's financial products are influential in promoting accessible credit, supporting economic activity, and fostering customer loyalty within numerous commercial sectors.
“Synchrony Financial trades at a P/E of 7.8 (undervalued) with strong ROE of 21.3%.”
Ask for details →Synchrony Financial (ticker: SYF) is a company listed on NYSE in the Financial Services sector (Credit Services). It has approximately 20,000 employees. Market cap is $27.8B.
The current price is $75.29 with a P/E ratio of 7.84x and P/B of 1.66x.
ROE is 21.30%. Annual revenue is $15.0B.